United States Securities and Exchange Commission · EDGAR Accession 0001669191-25-000418

Form C/A

Offering Statement Amendment — Regulation Crowdfunding
Campaign file 020-34896
Issuer CIK 1750795
Raising via NetCapital Funding Portal Inc.

Aphios Pharma LLC

Limited Liability CompanyDEIncorporated 2018North Reading, MAaphios.com
Nature of amendmentissuer extended the offering deadline.
A

The Offering

as disclosed in this filing
Common Stock
$3.44
$10,000
$617,999
October 1, 2025
Expired 256 days ago
$0max $617,999

Target is 2% of the maximum. Over-subscriptions accepted, allocated first-come, first-served basis.

B

Financial Condition

two fiscal years, as filed
Pre-revenueBurn increasing2 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(22,715)(822)▼ burn
Total assets00
Cash & equivalents00
Accounts receivable00
Short-term debt52,29139,583▲ 32%
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.

C

Campaign Timeline

file 020-34896 · all filings under this campaign
Loading campaign history…